The overall goal of this Program is to examine a protective role for innate immunity in autoimmune disease. Two murine models of autoimmunity will be characterized, i.e. systemic lupus erythematosus and rheumatoid arthritis. Four highly interrelated projects are proposed involving five senior investigators. The underlying theme connecting the four projects is the intimate role innate immunity plays in antigen clearance. Three of the projects will examine how self-reactive B- lymphocytes are negatively regulated by antigen in two well- characterized immunoglobulin transgenic models, i.e. hen lysozyme and dsDNA. Clonal deletion and receptor editing of self-reactive B- lymphocytes will be examined in mice deficient in innate proteins DNAse I, IgM, MBL, C1q, C4 and receptors CD21/CD35. Moreover, novel transgenic mice bearing an auto-reactive transgenic receptor or deficiency in Fas will be constructed using a conditional knock-in approach. The fourth project will examine if innate immunity is involved in T cell tolerance and/or elimination of self-antigen in the rheumatoid arthritis T-cell transgenic model. The significance of the program is that it not only addresses fundamental questions on regulation of adaptive immunity but could lead to novel therapies. Dissection of common pathways of innate immunity that protect against autoimmune disease could lead to therapeutic approaches with broad applications. A major strength of the Program is that it brings together senior investigators, each with specialized expertise, to interact in a synergistic manner.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI052343-01
Application #
6534614
Study Section
Special Emphasis Panel (ZAI1-NN-I (M1))
Program Officer
Johnson, David R
Project Start
2002-08-15
Project End
2007-05-31
Budget Start
2002-08-15
Budget End
2003-05-31
Support Year
1
Fiscal Year
2002
Total Cost
$1,329,263
Indirect Cost
Name
Immune Disease Institute, Inc.
Department
Type
DUNS #
115524410
City
Boston
State
MA
Country
United States
Zip Code
02115
Shannon, Jeffrey G; Cockrell, Diane C; Takahashi, Kazue et al. (2009) Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol 10:26
Guttormsen, Hilde-Kari; Stuart, Lynda M; Shi, Lei et al. (2009) Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination. Clin Immunol 130:264-71
Rajewsky, Klaus; von Boehmer, Harald (2008) Lymphocyte development: overview. Curr Opin Immunol 20:127-30
Monach, Paul A; Verschoor, Admar; Jacobs, Jonathan P et al. (2007) Circulating C3 is necessary and sufficient for induction of autoantibody-mediated arthritis in a mouse model. Arthritis Rheum 56:2968-74
Paul, Elahna; Nelde, Annette; Verschoor, Admar et al. (2007) Follicular exclusion of autoreactive B cells requires FcgammaRIIb. Int Immunol 19:365-73
Nguyen, Linh T; Jacobs, Jonathan; Mathis, Diane et al. (2007) Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 56:509-20
Koralov, Sergei B; Novobrantseva, Tatiana I; Konigsmann, Jessica et al. (2006) Antibody repertoires generated by VH replacement and direct VH to JH joining. Immunity 25:43-53
Hyatt, Gordon; Melamed, Rachel; Park, Richard et al. (2006) Gene expression microarrays: glimpses of the immunological genome. Nat Immunol 7:686-91
Stuart, Lynda M; Takahashi, Kazue; Shi, Lei et al. (2005) Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 174:3220-6
Koralov, Sergei B; Novobrantseva, Tatiana I; Hochedlinger, Konrad et al. (2005) Direct in vivo VH to JH rearrangement violating the 12/23 rule. J Exp Med 201:341-8

Showing the most recent 10 out of 13 publications